Marilena Vrana: Insights from the Alpha-1 Alliance Event on Advancing Plasma Access in the EU
Marilena Vrana, Vice President at the Plasma Protein Therapeutics Association (PPTA) Europe, shared on LinkedIn:
”Honoured to take part in the Alpha-1 Europe Alliance asbl event, hosted by MEP Olivier Chastel at the European Parliament.
Powerful patient stories and healthcare professionals insights on Alpha-1 Antitrypsin Deficiency highlighted a broader imperative: ensuring sustainable and equitable access to plasma-derived medicines for all patients across Europe.
From PPTA Europe perspective, one message is clear: achieving EU resilience and moving towards self-sufficiency in hashtag#plasma supply will require a truly collective effort.
Public, private and nonprofit collectors, healthcare professionals, patient communities, and policymakers all have a role to play.
This is particularly relevant in the context of implementing the EU SoHO Regulation.
Making its objectives a reality will depend on collaboration, aligned regulatory frameworks, and sustained investment, especially to scale up plasmapheresis capacity across all EU Member States.
Strengthening awareness, improving plasma collection capabilities, and coordinated action are essential steps to close the plasma supply gap and meet the real patient need.
Thank you to Flaminia Macchia for facilitating the discussion and to all panelists for this important exchange.”
Stay updated with Hemostasis Today.
-
Sep 11, 2026, 14:45Jorge Mascaro: The Growing Impact of the UK Aortic Society on Aortic Disease Care
-
Sep 11, 2026, 14:31Hany Ibrahim: Lp(a) Lowering Meets a Critical Test in the Lp(a)HORIZON Trial
-
Sep 11, 2026, 13:35How Non-Factor Therapies Are Changing Hemophilia Care – Seminars in Thrombosis and Hemostasis
-
Sep 11, 2026, 13:21Emmanuel J Favaloro: Rethinking Quality Control in VWD Testing
-
Sep 11, 2026, 13:10Tessa Youngner: New Free E-Course Introduces Comprehensive SCD Care
-
Sep 11, 2026, 12:55Identifying Key Research Priorities for VTE and Stroke – International Journal of Stroke
-
Sep 11, 2026, 12:43Helping Hematology Employers Reach Qualified Job Seekers – ASH
-
Sep 11, 2026, 12:22The First New Treatment for Essential Thrombocythemia in Nearly 30 Years
-
Sep 11, 2026, 12:20When Thrombosis Affects the Kidneys – World Thrombosis Day